Who to call at Essential Pharma, and when
Fundz watches for the moments Essential Pharma starts buying, and tells you who to reach.
- An alert the day Essential Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Essential Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Essential Pharma. With Fundz connected, it knows.
Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency.
Contract Type
partnership
Description
Essential Pharma Limited announces a partnership with Nordmark Pharma GmbH to commercialize Norzyme® (pancreas powder) 25,000 gastro-resistant capsules in the UK. This partnership leverages both companies' expertise in pancreatic enzymes, making the treatment available for patients with pancreatic exocrine insufficiency.
Quick answer
Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency. (November 9, 2026). Essential Pharma is based in Surrey, England, United Kingdom.
- What agreement did Essential Pharma announce on November 9, 2026?
- Essential Pharma Limited announces a partnership with Nordmark Pharma GmbH to commercialize Norzyme® (pancreas powder) 25,000 gastro-resistant capsules in the UK. This partnership leverages both companies' expertise in pancreatic enzymes, making the treatment available for patients with pancreatic exocrine insufficiency.
- What does Essential Pharma do?
- Essential Pharma is an international specialty pharmaceutical group dedicated to maintaining access to clinically differentiated, niche, branded medicines across multiple therapeutic areas.
- Where is Essential Pharma based?
- Essential Pharma is based in Surrey, England, United Kingdom.
- Which similar companies announced agreements around the same time?
- Daiichi Sankyo Healthcare Co (November 10, 2026), Sino Biopharmaceutical (November 13, 2026), Spektus Pharma (November 13, 2026) and Pfizer (November 14, 2026) also announced agreements within 45 days of Essential Pharma.
Source: Fundz verified event record.
Other recent agreements in Pharmaceutical and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Daiichi Sankyo and iDEL Therapeutics Forge Global Research Partnership for Cancer Drug Development. (November 10, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Spektus Pharma and GEBRO Holding Form Partnership for Global Commercialisation of ActraFlex® (November 13, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
Related People
Agreement Insights
What this usually meansEssential Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.